Amwell to Report First Quarter 2023 Operating Results and Host Conference Call on Wed., May 3, 2023
Amwell (NYSE: AMWL) will report its first-quarter 2023 operating results on May 3, 2023, at 5 p.m. Eastern time. Following the earnings release, the management team will host a live conference call to discuss results and provide updates.
Investors can access the live audio webcast on the Amwell Investors website or dial in at (888) 510-2008 for U.S. listeners and (646) 960-0306 internationally. The conference ID is 7830032, with a replay available for 90 days post-call.
Amwell is a leader in digital healthcare, with a platform used by over 2,000 hospitals and covering over 80 million lives. The company aims to enhance healthcare access and quality through digital solutions, supporting various care types.
- None.
- None.
A live audio webcast can be accessed by visiting the Investors section of the company's website at investors.amwell.com. Alternatively, please call (888) 510-2008 (
About Amwell
Amwell is a leading digital care delivery enablement platform in
Forward-Looking Statements
This press release contains forward-looking statements about us and our industry that involve substantial risks and uncertainties and are based on our beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” or “would,” or the negative of these words or other similar terms or expressions.
Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements represent our beliefs and assumptions only as of the date of this release. These statements, and related risks, uncertainties, factors and assumptions, include, but are not limited to: weak growth and increased volatility in the telehealth market; inability to adapt to rapid technological changes; increased competition from existing and potential new participants in the healthcare industry; changes in healthcare laws, regulations or trends and our ability to operate in the heavily regulated healthcare industry; our ability to comply with federal and state privacy regulations; the significant liability that could result from a cybersecurity breach; and other factors described under ‘Risk Factors’ in our most recent form 10-K filed with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20230419005026/en/
Investors:
Sue.dooley@amwell.com
415-602-9167
Press:
Angela.Vogen@amwell.com
Source: Amwell
FAQ
When will Amwell report its first-quarter 2023 results?
What time is Amwell's first-quarter earnings call?
How can I listen to Amwell's earnings call?
What is the conference ID for Amwell's earnings call?
What does Amwell do in the healthcare sector?
How many hospitals use Amwell's platform?